- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Fluticasone Propionate
Total 1085 results
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic Obstructive
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic Obstructive
-
Ramathibodi HospitalCompleted
-
Novartis PharmaceuticalsWithdrawnChronic Obstructive Pulmonary Disease
-
Chiesi Farmaceutici S.p.A.Completed
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Korea, Republic of, Chile, Poland, Czech Republic
-
Novartis PharmaceuticalsTerminated
-
Milton S. Hershey Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Egalet LtdCompleted
-
NovartisCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
GlaxoSmithKlineCompleted
-
ALK-Abelló A/SCompletedAllergy | Rhinitis | Conjunctivitis | Rhinoconjunctivitis
-
GlaxoSmithKlineCompletedAsthmaUnited States, Peru, Kenya, Puerto Rico
-
AstraZenecaCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveNetherlands
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, France, Romania, Finland, Taiwan, Bulgaria, Estonia, Canada, Netherlands, Philippines, South Africa, Sweden, Spain, Singapore, Austria, Germany, Latvia, New Zealand, China, Ukraine, Thailand, Greece, United Kingdom and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveRussian Federation, United States, Estonia, Chile
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Netherlands, Romania, Italy, Spain, Belgium, Denmark, Estonia, Sweden, Austria, Latvia, United Kingdom, Ukraine, Russian Federation, Greece, Czech Republic, Slovenia, Norway, Lithuania, Slovakia
-
GlaxoSmithKlineCompletedAsthmaPeru, Mexico, Argentina, Costa Rica, Turkey, Colombia, Venezuela
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
GlaxoSmithKlineCompletedHZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and AdolescentsAsthmaUnited States, Argentina, Korea, Republic of, Netherlands, Philippines, Chile
-
GlaxoSmithKlineCompletedAsthmaUnited States, Germany, Japan, Romania, Russian Federation, Poland
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Germany, Japan, Chile, Peru, Philippines, Poland, Mexico, Slovakia, Ukraine, South Africa, Puerto Rico, Georgia
-
GlaxoSmithKlineCompletedAsthmaRussian Federation, United States, Peru, Mexico, Netherlands, Poland
-
GlaxoSmithKlineCompletedAsthmaUnited States, United Kingdom
-
University of MiamiCompleted
-
GlaxoSmithKlineCompletedAsthmaUnited States, Estonia, Canada, Poland
-
GlaxoSmithKlineCompletedAsthmaUnited States, Russian Federation, Canada, Germany, Peru, Australia, Mexico, Chile, Costa Rica, Spain, Poland, Lithuania, Latvia
-
Mundipharma Research LimitedTerminatedACOS (Fixed Airflow Obstruction and Elevated Eosinophils)Slovakia
-
GlaxoSmithKlineCompletedRhinitis, Allergic, PerennialUnited States
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Philippines, Canada, Brazil
-
GlaxoSmithKlineCompletedRhinitis, Allergic, PerennialUnited States
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Canada, Philippines, Brazil
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
AstraZenecaCompletedAsthmaGermany, South Africa, Austria, Canada, Poland
-
AstraZenecaCompleted
-
AstraZenecaCompletedAsthmaSouth Africa, Germany, Brazil, Hungary, Poland, Portugal
-
AstraZenecaCompletedAsthmaUnited Kingdom, Switzerland, Belgium, France, Italy, Spain, Netherlands
-
AstraZenecaCompletedAsthmaHungary, South Africa, Poland, Spain, Canada, Australia, Czech Republic
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States